,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
enhertu could transform #breastcancer treatment, landmark her2-low trial suggests. #asco22
Latest medical news, articles, and features from Medscape Pharmacists.